|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/155 | (2006.01) |
| A61K 31/40 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 31/4439 | (2006.01) |
| (11) | Number of the document | 1948149 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06815305.5 |
| Date of filing the European patent application | 2006-09-25 | |
| (97) | Date of publication of the European application | 2008-07-30 |
| (45) | Date of publication and mention of the grant of the patent | 2011-11-16 |
| (46) | Date of publication of the claims translation | 2012-03-26 |
| (86) | Number | PCT/US2006/037198 |
| Date | 2006-09-25 |
| (87) | Number | WO 2007/041053 |
| Date | 2007-04-12 |
| (30) | Number | Date | Country code |
| 722624 P | 2005-09-29 | US |
| (72) |
JOSHI, Yatindra, US
KOWALSKI, James, US
LAKSHMAN, Jay, Parthiban, US
ROYCE, Alan, Edward, US
TONG, Wei-Qin, US
VASANTHAVADA, Madhav, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinė forma, apimanti metforminą ir vildagliptiną |
| FORMULATION COMPRISING METFORMIN AND VILDAGLIPTIN |
| Payment date | Validity (years) | Amount | |
| 2022-09-20 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-09-25 |